CHERINGTON CHARLES purchased 104.0% of their position (21.24M shares) of ERNEXA THERAPEUTICS INC. on the open market
Open‑market purchase worth $2.22M — a major conviction buy. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 6/11/2025ACC: 0001104659-25-058644
Director10% Owner
Since Mar 2021
+21.24M
Net shares
Net buyer
$2.22M
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
21.24M acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+21.24M
Price / share
$0.10
Trade value
$2.22M
% of position
104.0%
6/9/2025
20.42M→41.66M
Total
Net shares
+21.24M
Net value
$2.22M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/9/2025 | P · Purchase | +21.24M | $0.10 | $2.22M | 104.0% | 20.42M | 41.66M |
| Total | +21.24M | $2.22M | ||||||
Derivative Transactions0
No derivative transactions reported